Cirius Therapeutics
Latest round
- Series A
Last raised
- Aug 2018
Total raised
- $49M
Investors
- 5
About Cirius Therapeutics
Cirius Therapeutics, Inc.Cirius Therapeutics, Inc. was founded in 2015 and is headquartered in Kalamazoo, US. The company specializes in creating therapies for chronic metabolic diseases.Cirius Therapeutics develops innovative therapies focused on addressing diseases associated with insulin resistance, specifically targeting Type 2 Diabetes and Obesity. Their core product, 0602K, is designed to improve metabolic function and reduce insulin resistance, with ongoing research into its efficacy both as a standalone treatment and in combination with Tirzepatide.Cirius Therapeutics generates revenue through collaborative partnerships and clinical trial agreements with pharmaceutical companies and healthcare organizations. The business model is structured around B2B transactions, where agreements typically involve milestone payments connected to the progress of clinical trials and successful product development phases. The company is also exploring expansion opportunities into international markets by 2022, particularly in Europe and Asia, where the need for advanced therapeutic options for Type 2 Diabetes and Obesity is growing.
Who invested in Cirius Therapeutics
5 investors across 2 rounds
See all investors in Cirius Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cirius Therapeutics
Who invested in Cirius Therapeutics?
Cirius Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cirius Therapeutics raised?
Cirius Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cirius Therapeutics last raise money?
Cirius Therapeutics's most recent round on record is a Series A, in Aug 2018.
What does Cirius Therapeutics do?
Cirius Therapeutics is a pharmaceuticals company.
Where is Cirius Therapeutics headquartered?
Cirius Therapeutics is headquartered in Kalamazoo, US.
Which VCs invest in companies like Cirius Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cirius Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Cirius Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.